Cost-Effectiveness of Elbasvir (EBR, MK-8742)/Grazoprevir (GZR, MK-5172) Use in Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Virus (HCV) Genotype 1 Infection and Chronic Kidney Disease (CKD) in the United States

2016 ◽  
Vol 64 (2) ◽  
pp. S760
Author(s):  
E. Elbasha ◽  
W. Greaves ◽  
C. Nwankwo
Keyword(s):  
United States ◽  
Chronic Kidney Disease ◽  
Hepatitis C Virus ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Kidney Disease ◽  
The United States ◽  
Genotype 1 ◽  
Treatment Naïve ◽  
Hcv Genotype 1

scholarly journals FP267C-SURFER: GRAZOPREVIR PLUS ELBASVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION AND CHRONIC KIDNEY DISEASE

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii156-iii156 ◽  
Author(s):  
Annette Bruchfeld ◽  
David Roth ◽  
David Nelson ◽  
AnneMarie Liapakis ◽  
Marcelo Silva ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Treatment Naïve
Sign in / Sign up

Export Citation Format

Share Document